Company / Operating Cash Flow per Share
Cogent Biosciences, Inc. Operating Cash Flow per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$2.05
FY2025
5-year range
-$2.05 / -$1.52
FY2021-FY2025
Trend
-2.5%
vs FY2024
Sector context
#147 of 210
Health Care
What the data says
At $-2.05, Cogent Biosciences, Inc.'s operating cash flow per share ranks #147 of 210 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 9 years, ranging from $-5.45 in FY2019 to $-1.31 in FY2018.
Based on SEC 10-K filings.
-2.05 in FY2025.
Declined from $-1.93 to $-2.05 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#147 of 210 in Health CareTop 70% of 210This company -$2.05 Sector average $5.30
▼
-138.7% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 2.5% year-over-year.
- Ranks #147 out of 210 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2018.
- Lowest operating cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.05 | -2.5% |
| FY2024 | -$2.00 | -3.7% |
| FY2023 | -$1.93 | +4.5% |
| FY2022 | -$2.02 | -33.1% |
| FY2021 | -$1.52 | +53.1% |
| FY2020 | -$3.24 | +40.6% |
| FY2019 | -$5.45 | -317.5% |
| FY2018 | -$1.31 | +48.5% |
| FY2017 | -$2.53 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026